SPOTLIGHT: Melnyk drops suit against Biovail


Biovail founder Eugene Melnyk (photo) has withdrawn his lawsuit against the company and its current CEO after the two sides reached a tentative truce. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.